Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.

Steinherz PG, Gaynon PS, Breneman JC, Cherlow JM, Grossman NJ, Kersey JH, Johnstone HS, Sather HN, Trigg ME, Chappell R, Hammond D, Bleyer WA.

J Clin Oncol. 1996 Feb;14(2):389-98.

PMID:
8636748
2.

Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.

Steinherz PG, Gaynon PS, Breneman JC, Cherlow JM, Grossman NJ, Kersey JH, Johnstone HS, Sather HN, Trigg ME, Uckun FM, Bleyer WA.

Cancer. 1998 Feb 1;82(3):600-12.

PMID:
9452280
3.

Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia.

Lauten M, Möricke A, Beier R, Zimmermann M, Stanulla M, Meissner B, Odenwald E, Attarbaschi A, Niemeyer C, Niggli F, Riehm H, Schrappe M.

Haematologica. 2012 Jul;97(7):1048-56. doi: 10.3324/haematol.2011.047613.

4.
5.
8.

Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.

Conter V, Schrappe M, Aricó M, Reiter A, Rizzari C, Dördelmann M, Valsecchi MG, Zimmermann M, Ludwig WD, Basso G, Masera G, Riehm H.

J Clin Oncol. 1997 Aug;15(8):2786-91.

PMID:
9256120
10.
11.

[Initial response to therapy as an important prognostic factor in acute lymphoblastic leukemia in childhood. COALL study group].

Janka-Schaub GE, Stührk H, Kortüm B, Graubner U, Jürgens H, Spaar HJ, Schöck V, Dohrn B, Bahr R, Winkler K.

Klin Padiatr. 1991 Jul-Aug;203(4):231-5. German.

PMID:
1942930
12.

Prediction of outcome by early response in childhood acute lymphoblastic leukemia.

Möricke A, Lauten M, Beier R, Odenwald E, Stanulla M, Zimmermann M, Attarbaschi A, Niggli F, Schrappe M.

Klin Padiatr. 2013 May;225 Suppl 1:S50-6. doi: 10.1055/s-0033-1337964.

PMID:
23700057
13.

The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.

Güneş AM, Oren H, Baytan B, Bengoa SY, Evim MS, Gözmen S, Tüfekçi O, Karapınar TH, Irken G.

Ann Hematol. 2014 Oct;93(10):1677-84. doi: 10.1007/s00277-014-2106-0.

PMID:
24863691
14.

Prognostic value of day 14 blast percentage and the absolute blast index in bone marrow of children with acute lymphoblastic leukemia.

Visser JH, Wessels G, Hesseling PB, Louw I, Oberholster E, Mansvelt EP.

Pediatr Hematol Oncol. 2001 Apr-May;18(3):187-91.

PMID:
11293286
15.

Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.

Tzortzatou-Stathopoulou F, Papadopoulou AL, Moschovi M, Botsonis A, Tsangaris GT.

J Pediatr Hematol Oncol. 2001 Dec;23(9):591-7. Review.

PMID:
11902303
16.

Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia.

Panzer-Grümayer ER, Schneider M, Panzer S, Fasching K, Gadner H.

Blood. 2000 Feb 1;95(3):790-4. Erratum in: Blood 2000 May 15;95(10):3010.

17.
18.

Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features.

Gaynon PS, Bleyer WA, Steinherz PG, Finklestein JZ, Littman P, Miller DR, Reaman G, Sather H, Hammond GD.

Med Pediatr Oncol. 1990;18(4):273-9.

PMID:
2355886
19.

Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.

Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G.

Haematologica. 1998 Sep;83(9):791-9.

Items per page

Supplemental Content

Support Center